Orion - Changes board/management/auditors

Orion Corporation: Organising meeting of the Board of Directors

ORION   CORPORATION        STOCK  EXCHANGE  RELEASE    22 MARCH  2016 5.25 P.M.
EET


Orion Corporation: Organising meeting of the Board of Directors

In  its organising meeting,  the Board of  Directors of Orion Corporation, which
was elected today by the Annual General Meeting of the Shareholders, has elected
Timo Maasilta as Vice Chairman.

The compositions of the Board committees were decided to be as follows:

Remuneration Committee:
Hannu Syrjänen, Chairman
Mikael Silvennoinen
Heikki Westerlund
Jukka Ylppö

Audit Committee:
Heikki Westerlund, Chairman
Timo Maasilta
Eija Ronkainen
Mikael Silvennoinen

R&D Committee:
Sirpa Jalkanen, Chairman
Timo Maasilta
Eija Ronkainen
Mikael Silvennoinen
Hannu Syrjänen
Heikki Westerlund
Jukka Ylppö


The  members  to  the  Nomination  Committee  were elected on 29 October 2015 as
stated in the stock exchange release on the same day.

The  Board  of  Directors  has  assessed  the  independence  of  its members and
concluded  that  all  the  members  are  independent  of  the  company  and  its
significant shareholders.


Orion Corporation



Timo Lappalainen                   Olli Huotari
President and CEO                 Senior VP, Corporate Functions

Publisher:
Orion Corporation
Communications
Orionintie 1A, FI-02200 Espoo, Finland
Homepage: www.orion.fi

Orion  is a  globally operating  Finnish company  developing pharmaceuticals and
diagnostic  tests -  a builder  of well-being.  Orion develops, manufactures and
markets  human and veterinary pharmaceuticals, active pharmaceutical ingredients
and  diagnostic  tests.  The  company  is  continuously developing new drugs and
treatment  methods. The  core therapy  areas of  Orion's pharmaceutical  R&D are
central nervous system (CNS) disorders, oncology and respiratory for which Orion
developes inhaled Easyhaler® pulmonary drugs.

Orion's  net sales  in 2015 amounted  to EUR  1,016 million and  the company had
about 3,400 employees. Orion's A and B shares are listed on Nasdaq Helsinki.

[HUG#1996698]